 HOUSTON, March 08, 2022 GLOBE NEWSWIRE -- Bio-Path Holdings, Inc., NASDAQ: BPTH, a biotechnology company leveraging its proprietary DNAbilizeTM liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced an upcoming poster presentation at the 2022 American Association for Cancer Research AACR Annual Meeting, taking place in Atlanta, GA on April 8-13, 2022. 